U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

(Reuters) – The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body’s immune system to fight cancer.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply